AAAAAA

   
Results: 1-13 |
Results: 13
Morphologic analysis of BMP-9 gene therapy-induced osteogenesis
Authors: Varady, P Li, JZ Cunningham, M Beres, EJ Das, S Engh, J Alden, TD Pittman, DD Kerns, KM Kallmes, DF Helm, GA
Citation: P. Varady et al., Morphologic analysis of BMP-9 gene therapy-induced osteogenesis, HUM GENE TH, 12(6), 2001, pp. 697-710
Vein of galen aneurysmal malformation
Authors: Alden, TD Ojemann, JG Lytle, RA Park, TS
Citation: Td. Alden et al., Vein of galen aneurysmal malformation, PED NEUROS, 35(1), 2001, pp. 51-51
Fluoroscopic frameless stereotaxy for transsphenoidal surgery
Authors: Jane, JA Thapar, K Alden, TD Laws, ER
Citation: Ja. Jane et al., Fluoroscopic frameless stereotaxy for transsphenoidal surgery, NEUROSURGER, 48(6), 2001, pp. 1302-1307
A light and electron microscopic study of ectopic tendon and ligament formation induced by bone morphogenetic protein-13 adenoviral gene therapy
Authors: Helm, GA Li, JZ Alden, TD Hudson, SB Beres, EJ Cunningham, M Mikkelsen, MM Pittman, DD Kerns, KM Kallmes, DF
Citation: Ga. Helm et al., A light and electron microscopic study of ectopic tendon and ligament formation induced by bone morphogenetic protein-13 adenoviral gene therapy, J NEUROSURG, 95(2), 2001, pp. 298-307
Serum cortisol response to transsphenoidal surgery for Gushing disease
Authors: Simmons, NE Alden, TD Thorner, MO Laws, ER
Citation: Ne. Simmons et al., Serum cortisol response to transsphenoidal surgery for Gushing disease, J NEUROSURG, 95(1), 2001, pp. 1-8
The use of bone morphogenetic protein gene therapy in craniofacial bone repair
Authors: Alden, TD Beres, EJ Laurent, JS Engh, JA Das, S London, SD Jane, JA Hudson, SB Helm, GA
Citation: Td. Alden et al., The use of bone morphogenetic protein gene therapy in craniofacial bone repair, J CRANIOF S, 11(1), 2000, pp. 24-30
Bone morphogenetic proteins and bone morphogenetic protein gene therapy inneurological surgery: A review
Authors: Helm, GA Alden, TD Sheehan, JP Kallmes, D
Citation: Ga. Helm et al., Bone morphogenetic proteins and bone morphogenetic protein gene therapy inneurological surgery: A review, NEUROSURGER, 46(5), 2000, pp. 1213-1222
Use of bone morphogenetic protein-9 gene therapy to induce spinal arthrodesis in the rodent
Authors: Helm, GA Alden, TD Beres, EJ Hudson, SB Das, S Engh, JA Pittman, DD Kerns, KM Kallmes, DF
Citation: Ga. Helm et al., Use of bone morphogenetic protein-9 gene therapy to induce spinal arthrodesis in the rodent, J NEUROSURG, 92(2), 2000, pp. 191-196
In vivo endochondral bone formation using a bone morphogenetic protein 2 adenoviral vector
Authors: Alden, TD Pittman, DD Hankins, GR Beres, EJ Engh, JA Das, S Hudson, SB Kerns, KM Kallmes, DF Helm, GA
Citation: Td. Alden et al., In vivo endochondral bone formation using a bone morphogenetic protein 2 adenoviral vector, HUM GENE TH, 10(13), 1999, pp. 2245-2253
Mechanisms of premature closure of cranial sutures
Authors: Alden, TD Lin, KY Jane, JA
Citation: Td. Alden et al., Mechanisms of premature closure of cranial sutures, CHILD NERV, 15(11-12), 1999, pp. 670-675
Frameless stereotaxy for transsphenoidal surgery
Authors: Elias, WJ Chadduck, JB Alden, TD Laws, ER
Citation: Wj. Elias et al., Frameless stereotaxy for transsphenoidal surgery, NEUROSURGER, 45(2), 1999, pp. 271-275
Secondary gain influences the outcome of lumbar but not cervical disc surgery
Authors: Kaptain, GJ Shaffrey, CI Alden, TD Young, JN Laws, ER Whitehill, R
Citation: Gj. Kaptain et al., Secondary gain influences the outcome of lumbar but not cervical disc surgery, SURG NEUROL, 52(3), 1999, pp. 217-223
Percutaneous spinal fusion using bone morphogenetic protein-2 gene therapy
Authors: Alden, TD Pittman, DD Beres, EJ Hankins, GR Kallmes, DF Wisotsky, BM Kerns, KM Helm, GA
Citation: Td. Alden et al., Percutaneous spinal fusion using bone morphogenetic protein-2 gene therapy, J NEUROSURG, 90(1), 1999, pp. 109-114
Risultati: 1-13 |